A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study

Journal of Gastroenterology

Volumn 49, Issue 10, 2014, Pages 1392-1405

  Tominaga, Kazunari ^a   Kato, Mototsugu ^b   Takeda, Hiroshi ^c   Shimoyama, Yasuyuki ^d   Umegaki, Eiji ^e   Iwakiri, Ryuichi ^f   Furuta, Kenji ^g   Sakurai, Koichi ^h   Odaka, Takeo ⁱ   Kusunoki, Hiroaki ^j   Nagahara, Akihito ^k   Iwakiri, Katsuhiko ^l   Furuta, Takahisa ^m   Murakami, Kazunari ⁿ   Miwa, Hiroto ^o   Kinoshita, Yoshikazu ^g   Haruma, Ken ^j   Takahashi, Shin’ichi ^p   Watanabe, Sumio ^k   Higuchi, Kazuhide ^e   Kusano, Motoyasu ^d   Fujimoto, Kazuma ^f   Arakawa, Tetsuo ^a   more..

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c Department of Pathophysiology and Therapeutics ^*  (Japan)

^d GUNMA UNIVERSITY HOSPITAL   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

^f SAGA UNIVERSITY   (Japan)

^g SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^h KUMAMOTO UNIVERSITY   (Japan)

ⁱ CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j KAWASAKI MEDICAL SCHOOL   (Japan)

^k JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^m HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ OITA UNIVERSITY   (Japan)

^o HYOGO COLLEGE OF MEDICINE   (Japan)

^p KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Alternative medicine; Gastroesophageal reflux; Herbal medicine; Non erosive reflux disease; Quality of life

Indexed keywords

HERBACEOUS AGENT; PLACEBO; RABEPRAZOLE; RIKKUNSHITO; UNCLASSIFIED DRUG; LIU-JUN-ZI-TANG; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; FEMALE; FREQUENCY SCALE FOR THE SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE; GASTROINTESTINAL SYMPTOM RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NON EROSIVE REFLUX DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 8; TRADITIONAL MEDICINE; TREATMENT DURATION; CLINICAL TRIAL; DRUG COMBINATION; GASTROESOPHAGEAL REFLUX; MEDICATION COMPLIANCE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROTON PUMP INHIBITORS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84919467865     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0896-9     Document Type: Article

References (51)

1. Fujimoto K. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther. 2004;20(Suppl 8):5–8.
2. Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K. Strategy for treatment of nonerosive reflux disease in Asia. World J Gastroenterol. 2008;14:3123–8.
3. Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, Kashiwagi Y, et al. Proportion of reflux esophagitis in 6,010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol. 1999;34:441–4.
4. Shimazu T, Matsui T, Furukawa K, Oshige K, Mitsuyasu T, Kiyomizu A, et al. A prospective study of the prevalence of gastroesophageal reflux disease and confounding factors. J Gastroenterol. 2005;40:866–72.
5. Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005;40:1005–9.
6. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518–34.
7. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.
8. Coté GA, Howden CW. Potential adverse effects of proton pump inhibitors. Curr Gastroenterol Rep. 2008;10:208–14.
9. Fass R. Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs. 2007;67:1521–30.
10. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton pump inhibitor failure in gastro-oesophageal reflux disease. Where next? Aliment Pharmacol Ther. 2005;22:79–94.
11. Hershcovici T, Fass R. Nonerosive reflux disease (NERD)—an update. J Neurogastroenterol Motil. 2010;16:8–21.
12. Holloway RH, Dent J, Narielval F, Mackinnon AM. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut. 1996;38:649–54.
13. Futagami S, Iwakiri K, Shindo T, Kawagoe T, Horie A, Shimpuku M, et al. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol. 2010;45:413–21.
14. Tominaga K, Arakawa T. Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application. J Gastroenterol. 2013;48:452–62.
15. Hattori T, Fujitsuka N, Asakawa A, Inui A. A strategy using rikkunshito (Liu-Jun-Zi-Tang), a Japanese traditional medicine, to treat gastrointestinal disease. In: Satoh H, editor. Basics of evidences-based herbal medicine. Kerala: Research Signpost; 2010. p. 149–60.
16. Hayakawa T, Arakawa T, Kase Y, Akiyama S, Ishige A, Takeda S, et al. Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res. 1999;25:211–8.
17. Kido T, Nakai Y, Kase Y, Sakakibara I, Nomura M, Takeda S, et al. Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-l-arginine. J Pharmacol Sci. 2005;98:161–7.
18. Tominaga K, Kido T, Ochi M, Sadakane C, Mase A, Okazaki H, et al. The traditional Japanese medicine rikkunshito promotes gastric emptying via the antagonistic action of the 5-HT3 receptor pathway in rats. eCAM. 2009:1–8. doi:10.1093/ecam/nep173.
19. Kawahara H, Kubota A, Hasegawa T, Okuyama H, Ueno T, Ida S, et al. Effects of rikkunshito on the clinical symptoms and esophageal acid exposure in children with symptomatic gastroesophageal reflux. Pediatr Surg Int. 2007;23:1001–5.
20. Tominaga K, Iwakiri R, Fujimoto K, Fujiwara Y, Tanaka M, Shimoyama Y, et al. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. J Gastroenterol. 2012;47:284–92.
21. Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, et al. Development and evaluation of FSSG; frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888–91.
22. Muro Y, Sugiura K, Nitta Y, Mitsuma T, Hoshino K, Usuda T, et al. Scoring of reflux symptoms associated with scleroderma and the usefulness of rabeprazole. Clin Exp Rheumatol. 2009;27:15–21.
23. Fass R. Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment. J Clin Gastroemterol. 2007;41:437–44.
24. Fujikawa Y, Tominaga K, Fujii H, Machida H, Okazaki H, Yamagami H, et al. High prevalence of gastroesophageal reflux symptoms in patients with non-alcoholic fatty liver disease associated with serum levels of triglyceride and cholesterol but not simple visceral obesity. Digestion. 2012;86:228–37.
25. Tominaga K, Higuchi K, Iketani T, Ochi M, Kadouchi K, Tanigawa T, et al. Comparison of gastrointestinal symptoms and psychological factors of functional dyspepsia to peptic ulcer or panic disorder patients. Inflammopharmacology. 2007;15:84–9.
26. Miwa H, Nagahara A, Tominaga K, Yokoyama T, Sawada Y, Inoue K, et al. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol. 2009;104:2779–87.
27. Hill LD, Kozarek RA, Kraemer SJ, Aye RW, Mercer CD, Low DE, et al. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc. 1996;44(5):541–7.
28. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004;2:656–64.
29. Hershcovici T, Fass R. Step-by-step management of refractory gastroesophageal reflux disease. Dis Esophagus. 2013;26:27–36.
30. Kaji M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, Tanigawa T, et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol. 2010;25:1151–6.
31. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease—an analysis based on the ProGERD initiative. Aliment Pharmacol Ther. 2003;18:767–76.
32. Oh JH, Kim TS, Choi MG, Lee H, Jeon EJ, Choi SW, et al. Relationship between psychological factors and quality of life in subtypes of gastroesophageal reflux disease. Gut Liver. 2009;3:259–65.
33. Naito T, Itoh H, Takeyama M. Some gastrointestinal function regulatory Kampo medicines have modulatory effects on human plasma adrenocorticotropic hormone and cortisol levels with continual stress exposure. Biol Pharm Bull. 2003;26:101–4.
34. Sato Y, Katagiri F, Itoh H, Takeyama M. Effects of some kampo medicines on plasma levels of neuropeptide Y under venipuncture stress. Biol Pharm Bull. 2005;28:1757–61.
35. Fujitsuka N, Asakawa A, Uezono Y, Minami K, Yamaguchi T, Niijima A, et al. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Transl Psychiatry. 2011;26:e23.
36. Shiratori M, Shoji T, Kanazawa M, Hongo M, Fukudo S. Effect of rikkunshito on gastric sensorimotor function under distention. Neurogastroenterol Motil. 2011;23:323–9.
37. Cremonini F, Ziogas DC, Chang HY, Kokkotou E, Kelley JM, Conboy L, et al. Meta-analysis: the effects of placebo treatment on gastrooesophageal reflux disease. Aliment Pharmacol Ther. 2010;32:29–42.
38. Hongo M. Epidemiology of FGID symptoms in Japanese general population with reference to life style. J Gastroenterol Hepatol Suppl. 2011;26:19–22.
39. Pehlivanov N, Liu J, Mittal R. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Gastroenterol. 2001;281:743–51.
40. Xenos ES. The role of esophageal motility and hiatal hernia in esophageal exposure to acid. Surg Endosc. 2002;16:914–20.
41. Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003;17:243–51.
42. Fass R, Naliboff B, Higa L, Johnson C, Kodner A, Munakata J, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology. 1998;115:1363–73.
43. Sifrim D, Mittal R, Fass R, Smout A, Castell D, Tack J, et al. Acidity and volume of the refluxate in the genesis of gastrooesophageal reflux disease symptoms. Aliment Pharmacol Ther. 2007;25:1003–15.
44. Miwa H, Minoo T, Hojo M, Yaginuma R, Nagahara A, Kawabe M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2004;20:112–7.
45. Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012;61:1340–54.
46. Kusunoki H, Haruma K, Hata J, Ishii M, Kamada T, Yamashita N, et al. Efficacy of rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med. 2010;49:2195–202.
47. Miwa H, Koseki J, Oshima T, Kondo T, Tomita T, Watari J, et al. Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa. J Gastroenterol. 2010;45:478–87.
48. Araki Y, Mukaisho KI, Fujiyama Y, Hattori T, Sugihara H. The herbal medicine rikkunshito exhibits strong and differential adsorption properties for bile salts. Exp Ther Med. 2012;3:645–9.
49. Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008;134:2004–13.
50. Nahata M, Muto S, Oridate N, Ohnishi S, Nakagawa K, Sadakane C, et al. Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease. Am J Physiol Gastrointest Liver Physiol. 2012;303:G42–53.
51. Takeda H, Muto S, Hattori T, Sadakane C, Tsuchiya K, Katsurada T, et al. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition. Endocrinology. 2010;151:244–52.